skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Impact of bronchodilator therapy on exercise tolerance in COPD

Review

(3294) Views  (1104) Full article downloads

Authors: B Aguilaniu

Published Date March 2010 Volume 2010:5 Pages 57 - 71
DOI: http://dx.doi.org/10.2147/COPD.S7404

B Aguilaniu

HYLAB, Laboratory of Clinical Physiology and Exercise, Grenoble, France

Abstract: Exercise tolerance is an important parameter in patients with COPD and a primary goal of treatment is to reduce dyspnea to facilitate physical activities and improve health-related quality of life. This review examines the link between expiratory flow limitation and dyspnea to explain the rationale for the use of bronchodilators and review the characteristics of different types of exercise tests, with specific focus on which tests are likely to show a response to bronchodilators. An earlier literature search of studies published up to 1999 assessed the effects of bronchodilator therapy on dypsnea and exercise tolerance among patients with COPD. This current review examines the clinical evidence published since 1999. Thirty-one randomized studies of exercise tolerance associated with short- and long-acting β2-agonists and anticholinergics were identified. Evidence for the efficacy of bronchodilators in enhancing exercise capacity is often contradictory and possibly depends on the exercise test and study methodology. However, further studies should confirm the benefit of long-acting bronchodilators in improving spontaneous everyday physical activities.

Keywords: COPD, exercise, bronchodilator, walk test, exercise test








Readers of this article also read:

Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction
Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia
Preventing and managing exacerbations in COPD – critical appraisal of the role of tiotropium
Management of COPD in general practice in Denmark – participating in an educational program substantially improves adherence to guidelines
A day at a time: caregiving on the edge in advanced COPD
Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients
Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects
Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone
Development and implementation of treadmill exercise testing protocols in COPD
Safety of indacaterol in the treatment of patients with COPD
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio